OraSure Technologies, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From OraSure Technologies, Inc.
Emergency Use Authorizations on two Ebola tests and one for the Zika virus have been revoked by the US agency because it cleared the tests via more permanent pathways.
October’s approvals include the US FDA approval of Myriad’s myChoice CDx companion diagnostic for GlaxoSmithKline’s ovarian cancer drug and the approval or Medtronic’s Valiant Navion thoracic stent graft system in Japan.
To mark this year's World AIDS Day on Dec. 1, the World Health Organization has expanded its guidelines on HIV testing that will help increase the uptake of HIV self-testing – and a likely boost for manufacturers of these products – and improve HIV partner notification services.
Panelists will look at the benefits and risks of over-the-counter diagnostics for influenza, strep throat and sexually transmitted infections. The meeting is being held in response to sponsor queries about new test designs.
Diagnostic Imaging Equipment & Supplies
- Molecular Imaging
- Diagnostic Imaging Equipment & Supplies
In Vitro Diagnostics
- Chemistry, Immunoassay
- Therapeutic Drug Monitoring
- Urine-based Testing
- Other Names / Subsidiaries
- DNA Genotek